𝔖 Bobbio Scriptorium
✦   LIBER   ✦

3017 POSTER Cetuximab dose-escalation in patients (pts) with metastatic colorectal cancer (mCRC) with no or slight skin reactions on standard treatment: pharmacokinetic (PK), pharmacodynamic (PD) and efficacy data from the EVEREST study

✍ Scribed by Y. Humblet; M. Peeters; H. Gelderblom; J.B. Vermorken; F. Viret; B. Glimelius; F. Ciardiello; E. Gallerani; O. Kisker; E. van Cutsem


Book ID
118625787
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
58 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.